The HPA Axis: Understanding Your Brain's Stress Response System and Mental Health

The hypothalamic-pituitary-adrenal (HPA) axis is a complex neuroendocrine system that serves as the body's central stress response mechanism. It coordinates the interaction between three structures — the hypothalamus in the brain, the pituitary gland at the base of the brain, and the adrenal glands atop the kidneys — to regulate the production and release of cortisol, the body's primary stress hormone.

Think of the HPA axis as a biological alarm system. When the brain perceives a threat — whether it's a physical danger, a social conflict, a financial crisis, or even a stressful memory — the HPA axis activates a hormonal cascade designed to mobilize the body's resources for survival. This is a core component of what's often called the "fight-or-flight" response, though the HPA axis specifically governs the slower, more sustained hormonal phase of stress (as opposed to the rapid adrenaline surge driven by the sympathetic nervous system).

Under normal circumstances, the HPA axis is remarkably adaptive. It ramps up cortisol when needed, then efficiently shuts itself down through negative feedback loops once the stressor has passed. However, when stress is chronic, overwhelming, or occurs during critical developmental periods, this system can become dysregulated — stuck in overdrive, blunted into underactivity, or oscillating unpredictably. This dysregulation is now understood to be one of the most important biological mechanisms linking stress to mental illness.

The HPA axis operates through a precisely orchestrated hormonal cascade that unfolds over minutes rather than the milliseconds of a pure neural response:

• Step 1 — Threat Detection: Brain regions responsible for threat evaluation — primarily the amygdala (the brain's alarm center) and the prefrontal cortex (involved in cognitive appraisal of threat) — detect a stressor and send excitatory signals to the hypothalamus.
• Step 2 — CRH Release: The paraventricular nucleus (PVN) of the hypothalamus releases corticotropin-releasing hormone (CRH), also called corticotropin-releasing factor (CRF), into the portal blood system connecting the hypothalamus to the pituitary gland. CRH is the "ignition signal" of the entire cascade.
• Step 3 — ACTH Release: CRH stimulates the anterior pituitary gland to synthesize and secrete adrenocorticotropic hormone (ACTH) into the general bloodstream.
• Step 4 — Cortisol Release: ACTH travels to the adrenal cortex (the outer layer of the adrenal glands) and triggers the production and release of glucocorticoids, primarily cortisol in humans. Cortisol then circulates throughout the body and brain, producing wide-ranging metabolic, immune, and neural effects.
• Step 5 — Negative Feedback: Rising cortisol levels are detected by glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs) in the hypothalamus, pituitary, hippocampus, and prefrontal cortex. This signals the system to reduce CRH and ACTH production, effectively turning off the stress response. This negative feedback loop is critical — it prevents cortisol from remaining elevated indefinitely.

In addition to its stress-responsive function, the HPA axis maintains a circadian rhythm. Cortisol levels naturally peak in the early morning hours (the cortisol awakening response, or CAR) and decline throughout the day, reaching their lowest point around midnight. This diurnal pattern is essential for regulating energy, metabolism, immune function, and sleep-wake cycles. Disruptions to this rhythm are themselves associated with various psychiatric conditions.

While the hypothalamus, pituitary, and adrenal glands are the three named components, the HPA axis is regulated by a broader network of brain regions that determine when and how intensely the system activates:

• Amygdala: The amygdala is the primary activator of the HPA axis. It processes emotional stimuli — especially fear and threat — and sends excitatory projections to the hypothalamic PVN. An overactive amygdala, as observed in anxiety disorders and PTSD, can chronically drive HPA axis activation even in the absence of objective danger.
• Hippocampus: The hippocampus plays a crucial inhibitory role, helping to shut down the HPA axis after a stressor resolves. It is densely populated with glucocorticoid receptors and is therefore highly sensitive to cortisol levels. Critically, chronic cortisol exposure can damage hippocampal neurons, reduce hippocampal volume, and impair the hippocampus's ability to provide negative feedback — creating a vicious cycle of escalating stress reactivity.
• Prefrontal Cortex (PFC): The medial prefrontal cortex helps regulate the HPA axis through top-down cognitive control. It modulates emotional responses to stress by inhibiting amygdala activity and supporting context-dependent appraisal of threats. Impaired PFC function — as seen in chronic stress, depression, and trauma — weakens this regulatory capacity.
• Bed Nucleus of the Stria Terminalis (BNST): Sometimes called the "extended amygdala," the BNST is involved in sustained anxiety responses and anticipatory stress, as opposed to the acute, immediate fear responses driven by the central amygdala. It provides tonic excitatory input to the HPA axis during prolonged or uncertain threats.
• Locus Coeruleus–Norepinephrine System: The HPA axis works in concert with the sympathetic-adrenal-medullary (SAM) system, which releases norepinephrine and epinephrine (adrenaline) for rapid fight-or-flight responses. These two systems are reciprocally connected — CRH activates the locus coeruleus, and norepinephrine can stimulate CRH release, creating a positive feedback loop during acute stress.

The interplay among these regions determines whether the stress response is proportionate, excessive, or insufficient — and whether it resolves appropriately or persists long after the stressor has passed.

HPA axis dysfunction is not a mental health diagnosis in itself, but it is one of the most consistently documented biological findings across a range of psychiatric disorders. The nature of the dysregulation varies by condition:

Major Depressive Disorder (MDD)

HPA axis hyperactivity is one of the most replicated findings in biological psychiatry. Research consistently shows that a significant proportion of individuals with severe depression exhibit elevated basal cortisol levels, a flattened diurnal cortisol rhythm, and failure to suppress cortisol in the dexamethasone suppression test (DST) — a laboratory test that evaluates HPA axis negative feedback. The DSM-5-TR notes the association between MDD and HPA axis abnormalities as a supporting biological feature. Elevated CRH levels have been found in the cerebrospinal fluid of individuals with depression, and postmortem studies have revealed increased CRH-producing neurons in the hypothalamus. Importantly, hippocampal volume reductions observed in recurrent depression are believed to be partly driven by chronic cortisol neurotoxicity.

Post-Traumatic Stress Disorder (PTSD)

PTSD presents a paradox that challenged earlier assumptions about stress and cortisol. Rather than the hypercortisolism seen in depression, many individuals with PTSD demonstrate lower-than-expected basal cortisol levels with enhanced negative feedback sensitivity — meaning the HPA axis appears to be suppressed or overly efficient at shutting down. However, individuals with PTSD often show heightened cortisol reactivity to trauma-related cues and exaggerated CRH levels. This pattern may reflect a system that has been "reset" by extreme stress, potentially as an adaptation to chronic threat. Research also indicates that pre-existing low cortisol levels may be a risk factor for developing PTSD after trauma exposure, suggesting the HPA axis abnormality may precede the disorder in some cases.

Anxiety Disorders

Findings in anxiety disorders are somewhat heterogeneous. Generalized anxiety disorder (GAD) is often associated with elevated cortisol and a flattened diurnal rhythm. Panic disorder shows mixed results, with some studies finding elevated cortisol reactivity during panic attacks but relatively normal basal levels. Social anxiety disorder has been associated with altered cortisol responses to social-evaluative stress. The amygdala hyperactivation characteristic of anxiety disorders drives excessive HPA axis activation, particularly during anticipatory anxiety.

Early Life Adversity and Developmental Impact

Perhaps the most significant finding in HPA axis research is the profound impact of early life stress — including childhood abuse, neglect, and insecure attachment — on the developing stress response system. Adverse childhood experiences (ACEs) can fundamentally alter HPA axis programming through epigenetic mechanisms, particularly the methylation of the glucocorticoid receptor gene (NR3C1). Landmark research by Michael Meaney and colleagues demonstrated that early caregiving quality directly affects glucocorticoid receptor expression in the hippocampus, determining lifelong stress reactivity. These findings provide a biological mechanism explaining how childhood adversity increases vulnerability to depression, anxiety, PTSD, and other conditions across the lifespan.

Other Conditions

HPA axis abnormalities have also been documented in bipolar disorder (cortisol elevations during manic and depressive episodes), psychotic disorders (elevated cortisol associated with first-episode psychosis), borderline personality disorder (altered cortisol reactivity, particularly in those with childhood trauma histories), and chronic fatigue syndrome and burnout (hypocortisolism, sometimes termed "adrenal fatigue" in popular culture — though that term is clinically inaccurate).

The study of the HPA axis remains one of the most active areas in psychiatric neuroscience. Several lines of research are particularly noteworthy:

Epigenetics and Intergenerational Stress Transmission: Building on the foundational work on glucocorticoid receptor methylation, researchers are investigating how stress-related epigenetic changes may be transmitted across generations. Studies of offspring of Holocaust survivors, famine survivors, and mothers with PTSD have found altered HPA axis function and glucocorticoid receptor methylation patterns in their children — even in the absence of direct trauma exposure. While the mechanisms of intergenerational epigenetic transmission in humans remain debated, this research has profound implications for understanding how historical and systemic trauma may create biological vulnerability across generations.

Hair Cortisol as a Biomarker: Traditional cortisol measurement (blood, saliva, or urine) captures only acute or short-term cortisol levels and is highly variable. Hair cortisol concentration (HCC) has emerged as a promising method for measuring chronic cortisol exposure over weeks to months. Research has found elevated HCC in individuals with depression, individuals exposed to chronic stress, and children in adverse caregiving environments. While not yet a clinical diagnostic tool, HCC represents progress toward objective, long-term biomarkers of HPA axis function.

CRH Receptor Antagonists: Given the central role of CRH in driving the stress response, pharmaceutical researchers have explored CRH receptor type 1 (CRHR1) antagonists as potential treatments for depression, anxiety, and PTSD. Early-phase clinical trials have shown mixed results — some demonstrated improvements in anxiety and sleep but limited efficacy for core depressive symptoms. The pharmacological challenge of targeting CRH receptors with adequate brain penetration and specificity remains an active area of investigation.

The Gut-Brain-HPA Axis Connection: Emerging research on the microbiome-gut-brain axis has revealed bidirectional communication between gut microbiota and the HPA axis. Stress alters gut microbial composition, and On the other hand, gut microbiota can influence HPA axis reactivity. Germ-free animal models show exaggerated HPA axis responses to stress, which can be partially normalized by introducing specific bacterial strains. Human studies are still in early stages, but this research opens potential avenues for microbiome-targeted interventions in stress-related disorders.

Sex Differences: Research increasingly recognizes significant sex differences in HPA axis function. Estrogen and progesterone modulate HPA axis reactivity, contributing to the higher prevalence of stress-related disorders (depression, PTSD, anxiety) in women. Women tend to show greater cortisol reactivity to social rejection and interpersonal stress, while men show greater reactivity to achievement-based and competitive stressors. These findings have implications for understanding gender disparities in mental health.

Understanding HPA axis dysregulation has direct relevance to clinical practice, even though cortisol measurement is not yet a routine part of psychiatric assessment:

Psychotherapy and HPA Axis Normalization: Multiple studies have demonstrated that effective psychotherapy can normalize HPA axis function. Cognitive-behavioral therapy (CBT) for depression and anxiety has been associated with reductions in cortisol levels and improved diurnal cortisol rhythms. Trauma-focused therapies such as prolonged exposure (PE) and cognitive processing therapy (CPT) have shown evidence of altering cortisol reactivity patterns in PTSD. This provides a biological rationale for psychotherapy — it does not merely change thoughts and behaviors but can measurably alter neuroendocrine function.

Pharmacological Considerations: Several psychiatric medications interact with the HPA axis. Antidepressants, particularly SSRIs and SNRIs, have been shown to normalize elevated cortisol levels and restore glucocorticoid receptor sensitivity over the course of treatment. Some researchers have proposed that HPA axis normalization may be a mechanism of antidepressant action rather than merely a secondary effect. Mifepristone, a glucocorticoid receptor antagonist, has been studied in psychotic depression (which is strongly associated with hypercortisolism) with some promising results, though it remains experimental for psychiatric indications.

Lifestyle Interventions: A growing body of evidence supports the role of lifestyle factors in modulating HPA axis function:

• Exercise: Regular physical activity has been consistently shown to reduce basal cortisol levels, improve diurnal cortisol patterns, and enhance stress resilience. Both aerobic exercise and mind-body practices show benefits.
• Sleep: Sleep deprivation and disrupted sleep powerfully dysregulate the HPA axis, elevating evening cortisol and blunting the cortisol awakening response. Sleep hygiene is therefore a direct intervention for HPA axis health.
• Mindfulness and Meditation: Mindfulness-based stress reduction (MBSR) and similar practices have been associated with reduced cortisol levels and improved cortisol recovery after acute stressors in multiple controlled studies.
• Social Connection: Positive social relationships buffer HPA axis reactivity. Oxytocin, released during supportive social interaction, directly inhibits CRH release and dampens HPA axis activation.

Trauma-Informed Care: The understanding that early adversity can permanently alter HPA axis programming provides a strong scientific foundation for trauma-informed approaches in clinical practice. Recognizing that a person's stress reactivity patterns may be rooted in neurobiological changes — not simply in "overreacting" or lacking resilience — reduces stigma and guides more compassionate, effective treatment.

Misconception: "Adrenal fatigue" is a recognized medical diagnosis.

The concept of "adrenal fatigue" — the idea that chronic stress literally exhausts the adrenal glands, causing them to produce insufficient cortisol — is widely promoted in alternative health circles but is not recognized as a legitimate diagnosis by any major endocrine or psychiatric medical organization. A systematic review published in BMC Endocrine Disorders found no scientific evidence supporting adrenal fatigue as a distinct medical condition. While HPA axis hypoactivity (reduced cortisol output) does occur in some clinical contexts — such as PTSD, burnout syndrome, and chronic fatigue — this reflects altered central nervous system regulation of the HPA axis, not adrenal gland exhaustion. The distinction matters because it affects treatment approaches and prevents people from receiving appropriate evidence-based care.

Misconception: Cortisol is a "bad" hormone that should be minimized.

Popular health media frequently vilifies cortisol as a destructive "stress hormone" that causes weight gain, illness, and mental health problems. In reality, cortisol is essential for survival. It regulates blood sugar, reduces inflammation, supports immune function, consolidates memories, and maintains cardiovascular tone. The problem is not cortisol itself but the pattern of cortisol release — chronic elevation, inadequate recovery, blunted rhythms, or exaggerated reactivity. Completely suppressing cortisol (as occurs in Addison's disease) is life-threatening.

Misconception: A single cortisol test can diagnose a mental health condition.

Cortisol levels fluctuate dramatically throughout the day, across situations, and between individuals. A single blood cortisol measurement tells you very little about HPA axis function. Research studies use multiple sampling points, dynamic challenge tests (like the DST or the Trier Social Stress Test), or hair cortisol to assess HPA axis function meaningfully. No cortisol-based test is currently validated as a diagnostic tool for any psychiatric disorder.

Misconception: Stress responses are purely psychological — you can just "think your way out" of them.

While cognitive appraisal does influence HPA axis activation (the prefrontal cortex modulates the response), the stress response system has deep biological roots that operate partly below conscious awareness. Someone with early life adversity-related epigenetic changes to their glucocorticoid receptor gene will have a heightened stress response that is not simply a matter of having the wrong attitude. Understanding the biological basis of stress reactivity is essential for destigmatizing mental health conditions and for recognizing that treatment often needs to address both psychological and physiological dimensions.

Research on the HPA axis and mental health has matured considerably over the past several decades, but important uncertainties remain:

What is well-established:

• The HPA axis is a central mediator of the body's stress response, operating through the CRH → ACTH → cortisol cascade with negative feedback regulation.
• Chronic stress, particularly during early development, can produce lasting alterations in HPA axis function through epigenetic and structural brain changes.
• HPA axis hyperactivity is consistently associated with major depression, particularly melancholic and psychotic subtypes.
• PTSD is associated with a distinctive pattern of enhanced negative feedback sensitivity and often lower basal cortisol, distinguishing it from depression neurobiologically.
• The hippocampus is vulnerable to chronic cortisol exposure, and hippocampal volume reductions are observed in stress-related psychiatric conditions.
• Effective treatments — including psychotherapy, medication, exercise, and social support — can normalize HPA axis function.

What remains uncertain or debated:

• Whether HPA axis abnormalities are causes, consequences, or vulnerability markers for psychiatric disorders is not fully resolved. The relationship is likely bidirectional and varies by condition.
• The clinical utility of cortisol-based biomarkers for psychiatric diagnosis or treatment selection has not been established. Despite decades of research, no cortisol measure has entered routine clinical psychiatric practice.
• The extent and mechanisms of intergenerational epigenetic transmission of stress-related HPA axis changes in humans remain debated, with some researchers cautioning against overinterpreting findings from animal models.
• Why HPA axis findings show significant heterogeneity within diagnostic categories — not all people with depression show hypercortisolism, and not all people with PTSD show hypocortisolism — is an unresolved question that likely reflects the biological diversity within current diagnostic categories.
• The therapeutic potential of directly targeting HPA axis components (CRH antagonists, glucocorticoid receptor modulators) has not yet yielded clinically approved psychiatric treatments, though research continues.

The HPA axis remains one of the most important biological systems for understanding the mind-body connection in mental health. Its study has fundamentally shaped our understanding of how chronic stress "gets under the skin" and how early experiences shape lifelong vulnerability and resilience.

If you experience persistent patterns that suggest chronic stress may be affecting your mental or physical health, professional evaluation is warranted. These patterns include:

• Persistent feelings of being overwhelmed, anxious, or "on edge" that do not resolve with rest or removal of obvious stressors
• Chronic fatigue, sleep disruption, or a feeling of being "wired but tired"
• Difficulty recovering emotionally from stressors that others seem to manage
• Symptoms of depression — persistent low mood, loss of interest, changes in sleep and appetite — especially in the context of chronic or early life stress
• Intrusive memories, hypervigilance, or emotional numbing following traumatic experiences
• Physical symptoms associated with chronic stress, including unexplained weight changes, frequent illness, digestive problems, or chronic pain

A mental health professional — such as a psychiatrist, psychologist, or licensed clinical social worker — can conduct a comprehensive evaluation to determine whether your experiences align with a diagnosable condition and recommend evidence-based treatment. If you are concerned about the effects of chronic stress on your body, a primary care physician or endocrinologist can evaluate for medical conditions that affect cortisol (such as Cushing's syndrome or Addison's disease), which present differently from stress-related HPA axis dysregulation.

Understanding the biology of stress is empowering, but self-diagnosis based on cortisol theories or "adrenal fatigue" frameworks can lead to ineffective or harmful interventions. Evidence-based assessment and treatment remain the most reliable path to recovery.